Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non–small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non–small Cell Lung Cancer

Published:2018-10 Issue:10 Volume:41 Page:967-971
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Yoshimura Naruo,Tada Takuhito,Matsumoto Yoshiya,Sawa Kenji,Yoshimoto Naoki,Suzumura Tomohiro,Tanaka Hidenori,Mitsuoka Shigeki,Kimura Tatsuo,Tamiya Tomohiro,Hirashima Tomonori,Kawaguchi Tomoya,Kudoh Shinzoh,Hosono Masako,Hirata Kazuto

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference21 articles.

1. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study;Zatloukal;Lung Cancer,2004

2. Effect of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer;Schaake-Koning;N Engl J Med,1992

3. A single institutional subset analysis of the WJLCG study comparing concurrent and sequential chemoradiotherapy for stage III non-small-cell lung cancer;Tada;Radiat Med,2004

4. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma [Letter];Le Chevalier;J Natl Cancer Inst,1992

5. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose escalating conformal thoracic radiation therapy in unresectable stage IIIA/B non-small cell lung cancer: a modified phase I trial;Socinski;Cancer,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP